AstraZeneca CEO doubles down on U.S. amid rumors of listing shift CNBC 2025-07-29 13:57 Source Original site AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.